ArticleSystematic reviews2021

Efficacy and safety of CD22 chimeric antigen receptor (CAR) T cell therapy in patients with B cell malignancies: a protocol for a systematic review and meta-analysis.

Komal Adeel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.